Search This Blog

Wednesday, May 27, 2026

MIRA Pharmaceuticals amends Ketamir-2 license with MIRALOGX to secure worldwide rights

 

MIRA Pharmaceuticals amends Ketamir-2 license with MIRALOGX to secure worldwide rights and expanded patent portfolio

  • Amended Ketamir-2 license covers 10 major markets ahead of planned Phase 2a chemotherapy-induced peripheral neuropathy trial.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)